Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Insights and Forecast to 2028

Report ID: 1639730 | Published Date: Jan 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Buspirone
        1.2.3 Bupropion
        1.2.4 Testosterone
        1.2.5 Flibanserin
        1.2.6 Bremelanotide
        1.2.7 Cognitive Behavior Therapy
    1.3 Market by Application
        1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2017-2028)
    2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Region
        2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Dynamics
        2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Trends
        2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
        2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
        2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
        3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2017-2022)
        3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
    3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
        3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2021
    3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
    3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
    3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
    4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2023-2028)
5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
    5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
    6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
        6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
        6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
    6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
        6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
        6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
    6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
        6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
    7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
    7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
    7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        8.2.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        8.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
        8.4.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
    9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        9.2.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
    9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        9.3.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
    9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        9.4.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        10.2.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        10.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        10.4.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AMAG Pharmaceuticals
        11.1.1 AMAG Pharmaceuticals Company Details
        11.1.2 AMAG Pharmaceuticals Business Overview
        11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.1.5 AMAG Pharmaceuticals Recent Developments
    11.2 Allergan, Plc.
        11.2.1 Allergan, Plc. Company Details
        11.2.2 Allergan, Plc. Business Overview
        11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.2.5 Allergan, Plc. Recent Developments
    11.3 Ivix LLX
        11.3.1 Ivix LLX Company Details
        11.3.2 Ivix LLX Business Overview
        11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.3.5 Ivix LLX Recent Developments
    11.4 EndoCeutics, Inc.
        11.4.1 EndoCeutics, Inc. Company Details
        11.4.2 EndoCeutics, Inc. Business Overview
        11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.4.5 EndoCeutics, Inc. Recent Developments
    11.5 Emotional Brain BV
        11.5.1 Emotional Brain BV Company Details
        11.5.2 Emotional Brain BV Business Overview
        11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.5.5 Emotional Brain BV Recent Developments
    11.6 S1 Biopharma, Inc.
        11.6.1 S1 Biopharma, Inc. Company Details
        11.6.2 S1 Biopharma, Inc. Business Overview
        11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.6.5 S1 Biopharma, Inc. Recent Developments
    11.7 Sprout Pharmaceuticals, Inc.
        11.7.1 Sprout Pharmaceuticals, Inc. Company Details
        11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
        11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
        11.7.5 Sprout Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Buspirone
    Table 3. Key Players of Bupropion
    Table 4. Key Players of Testosterone
    Table 5. Key Players of Flibanserin
    Table 6. Key Players of Bremelanotide
    Table 7. Key Players of Cognitive Behavior Therapy
    Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2017-2022)
    Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2023-2028)
    Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
    Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
    Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
    Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
    Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Players (2017-2022)
    Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2021)
    Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
    Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2017-2022)
    Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2023-2028)
    Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2017-2022)
    Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2023-2028)
    Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 53. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 54. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 55. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 56. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 57. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 58. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 65. AMAG Pharmaceuticals Company Details
    Table 66. AMAG Pharmaceuticals Business Overview
    Table 67. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 68. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 69. AMAG Pharmaceuticals Recent Developments
    Table 70. Allergan, Plc. Company Details
    Table 71. Allergan, Plc. Business Overview
    Table 72. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 73. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 74. Allergan, Plc. Recent Developments
    Table 75. Ivix LLX Company Details
    Table 76. Ivix LLX Business Overview
    Table 77. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 78. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 79. Ivix LLX Recent Developments
    Table 80. EndoCeutics, Inc. Company Details
    Table 81. EndoCeutics, Inc. Business Overview
    Table 82. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 83. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 84. EndoCeutics, Inc. Recent Developments
    Table 85. Emotional Brain BV Company Details
    Table 86. Emotional Brain BV Business Overview
    Table 87. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 88. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 89. Emotional Brain BV Recent Developments
    Table 90. S1 Biopharma, Inc. Company Details
    Table 91. S1 Biopharma, Inc. Business Overview
    Table 92. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 93. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 94. S1 Biopharma, Inc. Recent Developments
    Table 95. Sprout Pharmaceuticals, Inc. Company Details
    Table 96. Sprout Pharmaceuticals, Inc. Business Overview
    Table 97. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 98. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022) & (US$ Million)
    Table 99. Sprout Pharmaceuticals, Inc. Recent Developments
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Buspirone Features
    Figure 3. Bupropion Features
    Figure 4. Testosterone Features
    Figure 5. Flibanserin Features
    Figure 6. Bremelanotide Features
    Figure 7. Cognitive Behavior Therapy Features
    Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2021 VS 2028
    Figure 9. Hospitals Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
    Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2021
    Figure 17. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2021
    Figure 19. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
    Figure 21. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
    Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
    Figure 23. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
    Figure 29. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Region (2017-2028)
    Figure 39. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
    Figure 49. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Country (2017-2028)
    Figure 55. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 59. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 60. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 61. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 62. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 63. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 64. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AMAG Pharmaceuticals
Allergan, Plc.
Ivix LLX
EndoCeutics, Inc.
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals, Inc.
Frequently Asked Questions
Hypoactive Sexual Desire Disorder (HSDD) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hypoactive Sexual Desire Disorder (HSDD) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hypoactive Sexual Desire Disorder (HSDD) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

USB Controllers

USB Controllers market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More